Advanced Medical Optics Inc. said Wednesday that it elected two new directors, including one from ValueAct Capital Partners LP, an activist hedge fund that’s the Santa Ana company’s largest stockholder.
The new directors are G. Mason Morfit, 32, a partner at San Francisco-based ValueAct, and Daniel Heinrich, 51, is senior vice president and chief financial officer for Clorox Co., the Oakland consumer products company.
The move increases Advanced Medical’s board to 10 members.
ValueAct’s Morfit also is a director at Valeant Pharmaceuticals International, the Aliso Viejo-based drug maker.
ValueAct is known as an activist shareholder that presses management to make changes. The fund now owns some 15% of Advanced Medical.
ValueAct and Jeffrey Ubben, its managing partner, opposed Advanced Medical’s $4.23 billion bid this summer for rival Bausch & Lomb Inc.
Advanced Medical eventually walked away from Bausch, which was bought by private equity firm Warburg Pincus LLC for $3.67 billion.
